Possibility As Role of Ginseng and Ginsenosides on Inhibiting the Heart Disease of COVID-19: A Systematic Review

Overview

Journal J Ginseng Res

Date 2022 Jan 24

PMID 35068945

Authors

Mohammad Amjad Hossain

Jong-Hoon Kim

Affiliations

Soon will be listed here.

Abstract

Coronavirus has been spreading rapidly around the world since it broke out in China in 2019. Respiratory diseases caused by coronavirus infection cause various diseases ranging from asymptomatic subclinical infections to severe pneumonia and cardiovascular complications, leading to death. In this regard, natural products are being studied to prevent various diseases caused by COVID-19. In current review, we would like to present mechanisms related to the inhibition of heart disease in ginseng and ginsenoside against SARS-CoV-2. In many previous studies, ginseng and ginsenoside are known to have antioxidant, blood flow improvement, improvement of vascular and heart function, blood pressure control, suppression of myocardial infarction and heart failure, and antiarrhythmia. Therefore, ginseng and ginsenoside have a possibility to suppress cardiovascular complications caused by COVID-19. Many of research provide evidence for ginseng and ginsenoside as treatments for the risk of cardiovascular complications. However, in this review, more specific contents on the proposition of the efficacy of ginseng and ginsenoside for COVID-19 should be presented. Therefore, we hope that researches to reduce cardiovascular complications of ginseng and ginsenoside for COVID-19 should be presented to reduce mortality for COVID-19.

Citing Articles

Antiviral potential of ginseng: Targeting human pathogenic viruses with compounds derived from ginseng.

Huo C, Baek J, Kim K J Ginseng Res. 2025; 49(2):105-117.

PMID: 40061485 PMC: 11889387. DOI: 10.1016/j.jgr.2024.12.004.

Protective effects of ginsenosides on ulcerative colitis: a meta-analysis and systematic review to reveal the mechanisms of action.

Yuan L, Li W, Hu S, Wang Y, Wang S, Tian H Inflammopharmacology. 2024; 32(5):3079-3098.

PMID: 38977646 DOI: 10.1007/s10787-024-01516-w.

and inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K.

Boopathi V, Nahar J, Murugesan M, Subramaniyam S, Kong B, Choi S Heliyon. 2023; 9(9):e19341.

PMID: 37809955 PMC: 10558348. DOI: 10.1016/j.heliyon.2023.e19341.

Compound K Production: Achievements and Perspectives.

Chu L, Hanh N, Quyen M, Nguyen Q, Lien T, Van Do K Life (Basel). 2023; 13(7).

PMID: 37511939 PMC: 10381408. DOI: 10.3390/life13071565.

Imaging-Navigated Surgery.

Lin Y, Zhang C, Liu C, Ma X, Yang Q, Guan B Adv Exp Med Biol. 2023; 1199:87-106.

PMID: 37460728 DOI: 10.1007/978-981-32-9902-3_5.

References

Kim M, Kang H, Baek C, Jung Y, Woo Y, Choi G . Antinociceptive and anti-inflammatory effects of ginsenoside Rf in a rat model of incisional pain. J Ginseng Res. 2018; 42(2):183-191. PMC: 5925619. DOI: 10.1016/j.jgr.2017.02.005. View

Xuan Y, Gao X, Holleczek B, Brenner H, Schottker B . Prediction of myocardial infarction, stroke and cardiovascular mortality with urinary biomarkers of oxidative stress: Results from a large cohort study. Int J Cardiol. 2018; 273:223-229. DOI: 10.1016/j.ijcard.2018.08.002. View

Uchimido R, Schmidt E, Shapiro N . The glycocalyx: a novel diagnostic and therapeutic target in sepsis. Crit Care. 2019; 23(1):16. PMC: 6337861. DOI: 10.1186/s13054-018-2292-6. View

Sawadogo N, Sanou H, Greene J, Duclos V . Promises and perils of mobile health in Burkina Faso. Lancet. 2021; 398(10302):738-739. DOI: 10.1016/S0140-6736(21)01001-1. View

Gimbrone Jr M, Garcia-Cardena G . Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ Res. 2016; 118(4):620-36. PMC: 4762052. DOI: 10.1161/CIRCRESAHA.115.306301. View

Morishita S, Shoji M, OGUNI Y, Ito C, Noguchi K, Sakanashi M . Effects of "kyushin", a drug containing toad venom, on experimental congestive heart failure in rabbits. Am J Chin Med. 1992; 20(1):83-9. DOI: 10.1142/S0192415X92000096. View

Wang X, Gu T, Shi E, Lu C, Wang C . Effect and mechanism of panaxoside Rg1 on neovascularization in myocardial infarction rats. Chin J Integr Med. 2010; 16(2):162-6. DOI: 10.1007/s11655-010-0162-4. View

Puelles V, Lutgehetmann M, Lindenmeyer M, Sperhake J, Wong M, Allweiss L . Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. 2020; 383(6):590-592. PMC: 7240771. DOI: 10.1056/NEJMc2011400. View

Lee D, Cho H, Kim H, Rhee M, Ryu J, Park H . Inhibitory effects of total saponin from Korean red ginseng via vasodilator-stimulated phosphoprotein-Ser(157) phosphorylation on thrombin-induced platelet aggregation. J Ginseng Res. 2013; 37(2):176-86. PMC: 3659637. DOI: 10.5142/jgr.2013.37.176. View

10.

Kim J, Byeon H, Im K, Min H . Effects of ginsenosides on regulatory T cell differentiation. Food Sci Biotechnol. 2018; 27(1):227-232. PMC: 6049740. DOI: 10.1007/s10068-017-0255-3. View

11.

Guan L, Li W, Liu Z . Effect of ginsenoside-Rb1 on cardiomyocyte apoptosis after ischemia and reperfusion in rats. J Huazhong Univ Sci Technolog Med Sci. 2003; 22(3):212-5. DOI: 10.1007/BF02828182. View

12.

Maffei Facino R, Carini M, Aldini G, Berti F, Rossoni G . Panax ginseng administration in the rat prevents myocardial ischemia-reperfusion damage induced by hyperbaric oxygen: evidence for an antioxidant intervention. Planta Med. 1999; 65(7):614-9. DOI: 10.1055/s-1999-14034. View

13.

Xiong T, Redwood S, Prendergast B, Chen M . Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020; 41(19):1798-1800. PMC: 7454513. DOI: 10.1093/eurheartj/ehaa231. View

14.

Yu C, Wong R, Wu E, Kong S, Wong J, Yip G . Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006; 82(964):140-4. PMC: 2596695. DOI: 10.1136/pgmj.2005.037515. View

15.

Chen C, Zhang H . [Protective effect of ginsenoside Re on isoproterenol-induced triggered ventricular arrhythmia in rabbits]. Zhongguo Dang Dai Er Ke Za Zhi. 2009; 11(5):384-8. View

16.

Zhang D, Hamdoun S, Chen R, Yang L, Ip C, Qu Y . Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry. Pharmacol Res. 2021; 172:105820. PMC: 8364251. DOI: 10.1016/j.phrs.2021.105820. View

17.

Deng J, Wang Y, Chen W, Wu Q, Huang X . Role of nitric oxide in ginsenoside Rg(1)-induced protection against left ventricular hypertrophy produced by abdominal aorta coarctation in rats. Biol Pharm Bull. 2010; 33(4):631-5. DOI: 10.1248/bpb.33.631. View

18.

Goshua G, Pine A, Meizlish M, Chang C, Zhang H, Bahel P . Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020; 7(8):e575-e582. PMC: 7326446. DOI: 10.1016/S2352-3026(20)30216-7. View

19.

Anderson T, Meredith I, Yeung A, Frei B, Selwyn A, Ganz P . The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995; 332(8):488-93. DOI: 10.1056/NEJM199502233320802. View

20.

Lubos E, Kelly N, Oldebeken S, Leopold J, Zhang Y, Loscalzo J . Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation. J Biol Chem. 2011; 286(41):35407-35417. PMC: 3195617. DOI: 10.1074/jbc.M110.205708. View